NCT02571959View on ClinicalTrials.gov

Pharmacokinetic Study of the Association of Amoxicillin / Clavulanic Acid to Obese Adults

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 24, 2015

Primary Completion Date

October 13, 2015

Study Completion Date

June 16, 2017

Conditions
Obesity
Interventions
DRUG

amoxicillin and clavulanic acid

Day 1 : a dose of amoxicillin and clavulanic acid 1g / 200mg will be intravenously administered

DRUG

amoxicillin and clavulanic acid

Day 2 : a dose of amoxicillin and clavulanic acid 1g / 125mg will be administered by oral route

Trial Locations (1)

92100

Hopital Ambroise Pare, Boulogne

All Listed Sponsors
lead

Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba

OTHER

NCT02571959 - Pharmacokinetic Study of the Association of Amoxicillin / Clavulanic Acid to Obese Adults | Biotech Hunter | Biotech Hunter